CARL ZEISS MEDITEC ADR 1 (AFXA) — Financial Flexibility Index
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of €144.16 Million (operating CF €144.16 Million minus capex €0.00) represents 0% of total liabilities (€1.28 Billion). Check CARL ZEISS MEDITEC ADR 1 (AFXA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CARL ZEISS MEDITEC ADR 1 Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of CARL ZEISS MEDITEC ADR 1.
Annual Financial Flexibility Index for CARL ZEISS MEDITEC ADR 1 (2022–2025)
Year-by-year free cash flow to debt coverage for CARL ZEISS MEDITEC ADR 1. Explore cash flow to debt ratio of CARL ZEISS MEDITEC ADR 1 to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | €286.45 Million | €209.86 Million | €1.28 Billion | ▼ -24.9% |
| 2024 | 0.30x | €399.52 Million | €247.32 Million | €1.34 Billion | ▼ -29.5% |
| 2023 | 0.42x | €364.72 Million | €250.86 Million | €860.02 Million | ▲ +24.4% |
| 2022 | 0.34x | €270.17 Million | €188.20 Million | €792.73 Million | — |